Affiris AG

Quick facts

Phase 2 pipeline

• active: AFFITOPE AD02

Phase 1 pipeline

• AFFITOPE AD01
• AFFITOPE AD01 adjuvanted
• AFFITOPE AD03
• AFFITOPE® PD01A · Neurology
  AFFITOPE® PD01A is designed to induce an immune response against alpha-synuclein, a protein implicated in Parkinson's disease.
• ATH03

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Affiris AG portfolio CI brief
• Affiris AG pipeline updates RSS